| 21st Nov 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 15th Nov 2023 3:00 pm |
RNS |
Block listing Interim Review |
| 13th Nov 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 13th Nov 2023 7:00 am |
RNS |
GSK receives positive CHMP opinion for momelotinib |
| 1st Nov 2023 3:00 pm |
RNS |
Total Voting Rights |
| 1st Nov 2023 7:00 am |
RNS |
3rd Quarter Results |
| 30th Oct 2023 7:00 am |
RNS |
Jemperli trial meets overall survival endpoint |
| 26th Oct 2023 7:00 am |
RNS |
NMPA approves Vocabria+Rekambys in China |
| 25th Oct 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 25th Oct 2023 7:00 am |
RNS |
New data for Arexvy, GSK’s RSV vaccine |
| 20th Oct 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 18th Oct 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 17th Oct 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 16th Oct 2023 7:00 am |
RNS |
Jemperli plus chemotherapy positive CHMP opinion |
| 13th Oct 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 12th Oct 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 11th Oct 2023 7:00 am |
RNS |
Zantac (ranitidine) litigation |
| 10th Oct 2023 11:00 am |
RNS |
Holding(s) in Company |
| 9th Oct 2023 7:00 am |
RNS |
GSK and Zhifei announce vaccine partnership |
| 6th Oct 2023 7:00 am |
RNS |
GSK completes sale of shares in Haleon plc |
| 5th Oct 2023 4:46 pm |
RNS |
GSK announces intention to sell shares in Haleon |
| 2nd Oct 2023 3:00 pm |
RNS |
Total Voting Rights |
| 27th Sep 2023 3:00 pm |
RNS |
Directorate Change |
| 25th Sep 2023 7:00 am |
RNS |
GSK RSV vaccine for older adults approved in Japan |
| 21st Sep 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 19th Sep 2023 7:00 am |
RNS |
Apretude for PrEP receives EMA approval |
| 18th Sep 2023 7:00 am |
RNS |
FDA approves Ojjaara (momelotinib) |
| 13th Sep 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 11th Sep 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 11th Sep 2023 7:00 am |
RNS |
Momelotinib filing accepted in Japan |
| 1st Sep 2023 3:00 pm |
RNS |
Total Voting Rights |
| 1st Sep 2023 7:00 am |
RNS |
GSK’s Nucala CRSwNP submission accepted in Japan |
| 31st Aug 2023 3:16 pm |
RNS |
Holding(s) in Company |
| 31st Aug 2023 3:14 pm |
RNS |
Holding(s) in Company |
| 25th Aug 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Aug 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Aug 2023 7:00 am |
RNS |
Shingrix data demonstrate 100% efficacy in China |
| 22nd Aug 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 10th Aug 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 9th Aug 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
